{
    "Trade/Device Name(s)": [
        "VITEK\u00ae 2 Yeast Fluconazole",
        "VITEK 2 AST-YS Fluconazole"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K061945",
    "Predicate Device Reference 510(k) Number(s)": [
        "K991810"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NGZ"
    ],
    "Summary Letter Date": "September 19, 2006",
    "Summary Letter Received Date": "July 10, 2006",
    "Submission Date": "July 6, 2006",
    "Regulation Number(s)": [
        "21CFR866.1645"
    ],
    "Regulation Name(s)": [
        "Fully automated short-term incubation cycle antimicrobial susceptibility system"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "mycology"
    ],
    "Analyte(s)": [
        "Fluconazole"
    ],
    "Specimen Type(s)": [
        "Isolated colonies of yeast",
        "Candida species"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITEK 2 System"
    ],
    "Method(s)/Technology(ies)": [
        "Antifungal susceptibility testing",
        "Minimum inhibitory concentration (MIC) determination",
        "Automated incubation and reading"
    ],
    "Methodologies": [
        "Microdilution",
        "Automated antimicrobial susceptibility testing"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK 2 Yeast Fluconazole assay for automated antifungal susceptibility testing using the VITEK 2 System",
    "Indications for Use Summary": "Intended for antifungal susceptibility testing of Candida species as a quantitative test to determine in vitro susceptibility to antifungal agents using the VITEK 2 System",
    "fda_folder": "Microbiology"
}